Skip to main content

Is Plasma Therapy Market Trapped Between Growth Expectations And Uncertainty?

  The Covid-19 pandemic is anticipated to affect the worldwide computer aided drug discovery market positively. The respiratory disease therapeutic segment will generate a considerable amount of the global market share. The pharmaceutical end-user segment is anticipated to reach newer heights. The structure-based drug design segment is foreseen to overwhelm the global market share. The Asia-Pacific region will generate huge investment opportunities in the conjecturetime frame. The key players of the market are concentrating on various strategies to sustain in these trying times.

Download Exclusive Free Sample Copy of the Report: https://www.researchdive.com/request-toc-and-sample/208

The sudden eruption of COVID-19 pandemic has imposed positive impact on the computer aided drug discovery market. Widespread coronavirus has influenced numerous medical organizations for the advancement of vaccines to treat infected persons around the world. According to a recent publication by Pharmaceutical Science and Computational Chemical Genomics Screening Centre, distinguishing proof of antibody or medication treatment for COVID-19 is studied using the computational drug repurposing method. This study has contributed to the development of vaccine for COVID-19 infection. Also besides, it stated that computer-aided drug design is an efficient procedure to contemplate the 3-dimensional structure of virus protein. Likewise, chloroquine phosphate is utilized for the treatment of COVID-19 infected persons. But according to publication made by Dr. Talluri Sekhar, this chloroquine is used to treat a few patients. Thus several studies are carried out to study the genomic structure and develop chloroquine with the help of computer-aided technology to utilize it on severely ill patients.

In addition, a team of Chinese scientists stated that the high-resolution crystal structure of the COVID-19 virus has been studied and developed an antiviral drug that can combat the virus. This protease structure was studied using virtual drug screening and structure-assist drug design. Thus these factors are driving the demand of the global computer aided drug discovery market in the forecast period of time. During this unique situation, our analysts are helping our clients in understanding the impact of COVID19 on the Computer aided drug discovery Market by providing them with an in-depth analysis.

As per a recent report published by Research Dive, the global computer aided drug discovery market is set to generate a revenue of $5,427.2 billion by 2026, at a CAGR of 16.9% during the forecast period from 2019 to 2026.

The global CADD market has been fragmented on the basis of type, therapeutic area, end-user and region. The computer aided drug discovery report provides in-depth insights on drivers, vital segments, opportunities, restraints, and key players of the market. As per our analysts, increased utilization of CADD method for various phase of drug development is expected to drive the global computer aided drug discovery market. However,it is difficult to copy and simulate the complete biological system on a computer system and flexibility are the factors restraining the market growth.

Structure-Based Drug Design Type to Have Dominant Share

Based on type, the global computer aided drug discovery market is classified into structure-based drug design (SBDD), ligand-based drug design (LBDD), and sequence-based approaches. The structure-based drug design segment represented $489.8 billion income in 2018 and is anticipated to develop at 17.3% CAGR by the end of 2026. This design is the developing iterative and ground-breaking approach for auxiliary assessment of drug discovery process and it is cost-effective method as compared to other design type.

Connect with Analyst to Reveal How COVID-19 Pandemic Impacting On Market: https://www.researchdive.com/connect-to-analyst/208

Respiratory Disease Therapeutic Area to be Most Lucrative

In view oftherapeutic area, the global market for the computer aided drug discovery is segmented into oncology, neurology, cardiovascular disease, respiratory disease, diabetes and others. The market size for the respiratory disease accounted for $243.4 billion in 2018 and is estimated to grow with the highest CAGR of 17.3% CAGR by 2026. This development is attributed to the fast ascent in the respiratory issues due to growing prevalence for smoking and COVID-19 patients.

Pharmaceutical Companies to be Most Lucrative

On the basis of end-user, the computer aided drug discovery market is divided into pharmaceutical companies, biotechnology companies, research institutes and others. Pharmaceutical company segment is anticipated to dominate the global computer aided drug discovery market. Pharmaceutical company vertical accounted for $452.9 billion in 2018 and is projected to grow with a CAGR of 17.2% during the projected time frame. The growth is attributed due to the increasing demand for development of appropriate vaccine to treat COVID-19 patients around the world.

Geographical Analysis and Major Market Players

Based on the region, the global computer aided drug discovery market is segmented into North America, Europe, Asia Pacific, and LAMEA. The Asia-Pacific computer aided drug discovery market accounted for $411.3 billion in 2018 and is anticipated to rise at 17.6% CAGR throughout the forecast period. The growth is majorly attributed to the presence of major key-players in this region and their increasing investments for research & development activities to widen the utilization of CADD.

The major players of the global computer aided drug discovery market include BOC Sciences, BioDuro, Schrödinger, Aris Pharmaceuticals, Aragen Bioscience, Albany Molecular Research Inc. (AMRI), Charles River, AstraZeneca, Evotec A.G., and Bayers AG.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Toll Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Comments

Popular posts from this blog

How COVID-19 Pandemic Will Impact on Organ Care System Market For Lungs Growth in 2020 and Coming Future?

   The spread of the COVID-19 pandemic has brought a positive impact on the global organ care system for the lungs industry. Lung transplantation is still witnessing newer heights in the global market. Key players are highlighting mainly on the newer and innovative business strategies to strengthen the footprint in the market during and post-pandemic period. The recently published research report by Research Dive reflects on the influence of COVID-19 pandemic on the present and forthcoming growth of the global organ care system for lungs industry. This is professional and all-inclusive research articulated by specialists by evaluating the major growth driving factors, important regional market situations, future opportunities and scope, and trends & developments in the market during the COVID-19 outbreak. Download FREE Sample at:   https://www.researchdive.com/download-sample/341 Highlights of the Report: The market is anticipated to perceive growth owing to the mounting demand for

How COVID-19 Pandemic Will Impact on Pneumonia Therapeutics Market Growth and Demand in 2020 and Coming Future?

   The pneumonia therapeutics market is predicted to have a positive impact in 2020. Increasing cases of pneumococcal disease is predicted to drive the market in the forecast period. Pneumonia is mostly caused due to the infection in the lungs. At present the symptoms of coronavirus are most similar to that of pneumonia due to which most of the companies are focusing more on their research and development activities to launch new products to treat both the deadly diseases. For instance, in July 2020 NABRIVA received European approval for XENLETA (lefamulin) for treatment of community-acquired pneumonia (CAP). XENLETA is the first new antibiotic approved for patients with CAP in Europe. During this unpredicted situation, we are helping our clients in understanding the impact of COVID19 on the global market. According to a study conducted by Research Dive,  the global pneumonia therapeutics market is expected to register a revenue of $3,147.7 million till 2027, growing at a rate of 8.2%

Why Dynamics of Laboratory Temperature Control Units Market Is Changing Drastically? What If History Is Any Guide?

   The worldwide spread of COVID-19 has positively impacted the global laboratory temperature control units market. This is mainly because various market players are taking initiatives to such as new innovations and novel technologies to fight the challenges created by COVID-19 outbreak. Furthermore, the global market is expected to observe substantial growth even after the pandemic owing to increasing adoption of laboratory temperature control units in the various industries such as pharmaceuticals, food & beverages, and cosmetics. The  global laboratory temperature control units market  is likely to experience an increase in the growth rate during the COVID-19 pandemic. As per a new report added by Research Dive, the global laboratory temperature control units market is anticipated to reach up to $833.83 million during the forecast period from 2019 to 2026. Comprehensive analysis on drivers, challenges, growth opportunities, major segments, and key strategies executed by major ma